Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Sharp

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Experimental Hematology|July 1, 1995
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignanciesA Kessinger, M R Bishop, J D Jackson, et al.
Leukemia & Lymphoma|December 1, 1995
Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agentsA G Wu, S S Joshi, W C Chan, et al.
Mechanisms of Ageing and Development|November 2, 2010
Human blood and marrow side population stem cell and Stro-1 positive bone marrow stromal cell numbers decline with age, with an increase in quality of surviving stem cells: correlation with cytokinesS K Brusnahan, T R McGuire, J D Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignanciesM R Bishop, P L Iversen, E Bayever, et al.
Leukemia|December 3, 2013
Tumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesisS L Peters, R A Hlady, J Opavska, et al.
Leukemia & Lymphoma|November 9, 2001
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cellsJ G Sharp, M R Bishop, B Copple, et al.
Journal of Hematotherapy|November 22, 1997
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndromeM R Bishop, J D Jackson, S R Tarantolo, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
On the safety of 5-[125I]iodo-2'-deoxyuridine--Preclinical evaluation in swineJ Baranowska-Kortylewicz, G V Dalrymple, K A Harrison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Radiolabeled iododeoxyuridine: safety evaluationK A Harrison, G V Dalrymple, J Baranowska-Kortylewicz, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Experimental Hematology|July 1, 1995
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignanciesA Kessinger, M R Bishop, J D Jackson, et al.
Leukemia & Lymphoma|December 1, 1995
Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agentsA G Wu, S S Joshi, W C Chan, et al.
Mechanisms of Ageing and Development|November 2, 2010
Human blood and marrow side population stem cell and Stro-1 positive bone marrow stromal cell numbers decline with age, with an increase in quality of surviving stem cells: correlation with cytokinesS K Brusnahan, T R McGuire, J D Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignanciesM R Bishop, P L Iversen, E Bayever, et al.
Leukemia|December 3, 2013
Tumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesisS L Peters, R A Hlady, J Opavska, et al.
Leukemia & Lymphoma|November 9, 2001
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cellsJ G Sharp, M R Bishop, B Copple, et al.
Journal of Hematotherapy|November 22, 1997
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndromeM R Bishop, J D Jackson, S R Tarantolo, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
On the safety of 5-[125I]iodo-2'-deoxyuridine--Preclinical evaluation in swineJ Baranowska-Kortylewicz, G V Dalrymple, K A Harrison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Radiolabeled iododeoxyuridine: safety evaluationK A Harrison, G V Dalrymple, J Baranowska-Kortylewicz, et al.
Pageof 15